Replies to post #411163 on Anavex Life Sciences Corp (AVXL)

[BIOChecker4]

I agree except that by my calculation the cost would drop to $3652.25, not $3652.50.

[Steady_T]

I doubt that you are figuring in the amortization of the development costs and the additional costs of growing the company.

It seems likely to me that the cost per year will be considerably higher than you project. Especially for the initial Rett approval. Once AD is approved the cost of the drug will come down dramatically but it will come down from a much higher initial price than you project.

We shall see what the reality is when the drug gets on the market.